Interestingly, gene expression of the FXR and the FGF19 receptor in liver tissue was not altered in NAFLD pigs, suggesting that the impairment of FXR signaling in NAFLD pigs may be associated with reduced FXR activation. The gene discussed is NR1H4; the disease is metabolic dysfunction-associated steatotic liver disease.